Liver cancer ablation with extracorporeal high-intensity focused ultrasound

R. Yang, N. T. Sanghvi, F. J. Rescorla, K. K. Kopecky, J. L. Grosfeld

Research output: Contribution to journalReview article

63 Scopus citations


Recent animal studies have demonstrated the capacity of high-intensity focused ultrasound (HIFU) to extracorporeally ablate selective tissue targets in the liver without requiring surgical exposure of the liver or insertion of instruments into the liver. The potential value of HIFU as a noninvasive local treatment for human hepatic cancers has attracted considerable interest. This report reviews the current status of HIFU research and sets forth questions for future study.

Original languageEnglish (US)
Pages (from-to)17-22
Number of pages6
JournalEuropean urology
Issue numberSUPPL. 1
StatePublished - Jan 1 1993


  • Intense focused ultrasound
  • Liver cancer
  • Noninvasive therapy

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Liver cancer ablation with extracorporeal high-intensity focused ultrasound'. Together they form a unique fingerprint.

  • Cite this